Abbott’s $23 Billion Cancer Gambit: Snapping Up Exact Sciences to Revolutionize Diagnostics
In a blockbuster move shaking up the healthcare sector, Abbott Laboratories announced on Thursday its acquisition of Exact Sciences Corp. for up to $23 billion, including debt. This deal, one of the largest in Abbott’s recent history, aims to fortify its …